CoChat

Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

CONTEXT: Metformin is widely prescribed to pregnant women with polycystic ovary syndrome (PCOS) in an attempt to reduce pregnancy complications. Metformin is not approved for this indication, and evidence for this practice is lacking. OBJECTIVES: Our objective was to test the hypothesis that metformin, from first trimester to delivery, reduces pregnancy complications in women with PCOS. DESIGN AND SETTING: We conducted a randomized, placebo-controlled, double-blind, multicenter study at 11 secondary care centers. PARTICIPANTS: The participants were 257 women with PCOS, in the first trimester of pregnancy, aged 18-42 yr. INTERVENTION: We randomly assigned 274 singleton pregnancies (in 257 women) to receive metformin or placebo, from first trimester to delivery. MAIN OUTCOME MEASURES: The prevalence of preeclampsia, gestational diabetes mellitus, preterm delivery, and a composite of these three outcomes is reported. RESULTS: Preeclampsia prevalence was 7.4% in the metformin group and 3.7% in the placebo group (3.7%; 95% CI, -1.7-9.2) (P=0.18). Preterm delivery prevalence was 3.7% in the metformin group and 8.2% in the placebo group (-4.4%; 95%, CI, -10.1-1.2) (P=0.12). Gestational diabetes mellitus prevalence was 17.6% in the metformin group and 16.9% in the placebo group (0.8%; 95% CI, -8.6-10.2) (P=0.87). The composite primary endpoint prevalence was 25.9 and 24.4%, respectively (1.5%; 95% CI, -8.9-11.3) (P=0.78). Women in the metformin group gained less weight during pregnancy compared with those in the placebo group. There was no difference in fetal birth weight between the groups. CONCLUSIONS: Metformin treatment from first trimester to delivery did not reduce pregnancy complications in PCOS.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2010-0853

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 316

Metadata

Authors
Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K. F., Bunford, G., Lund, A., Bjerke, C., Almås, I., Berg, A. H., Danielson, A., Lahmami, G., & Carlsen, S. M.
Affiliations
  • Norwegian University of Science and Technology (NO)
  • St Olav's University Hospital (NO)
  • Department of Public Health (P.R.) Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway;
  • Sentral Hospital of Northern Norway (K.S.), 8092 Bodø, Norway;
  • Elvebredden Gynekologpraksis (O.K.), 4630 Kristiansand, Norway;
  • Ålesund Hospital (NO)
  • Stavanger University Hospital (P.v.B.), 4011 Stavanger, Norway;
  • Haugesund Hospital (T.E.), 5504 Haugesund, Norway;
  • UiT The Arctic University of Norway (NO)
  • Drammen Hospital (NO)
  • Ringerike Hospital (G.B.), 5311 Hønefoss, Norway;
  • University of Bergen (NO)
  • Lillehammer Hospital (C.B., A.H.B., A.D.), 2629 Lillehammer, Norway
  • Buskerud Hospital (K.F.B., I.A.), 3004 Drammen, Norway;
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2010-12-01
Volume
95
Issue
12
Pages
E448-E455
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1986803895
Cited by
315
References
28
Citations by year
2026: 6 · 2025: 12 · 2024: 18 · 2023: 20 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 24 · 2017: 16 · 2016: 21 · 2015: 17 · 2014: 25 · 2013: 30 · 2012: 20
FWCI
28.02
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
Helse Midt-Norge
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
metformin, polycystic ovary syndrome, pregnancy complications, preeclampsia, gestational diabetes mellitus, preterm birth, gestational weight gain, birth weight, first trimester
MeSH terms
Adult, Blood Pressure, Double-Blind Method, Female, Heart Rate, Humans, Metformin, Patient Compliance, Placebos, Polycystic Ovary Syndrome, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Trimester, First, Random Allocation, Diabetes, Gestational, Delivery, Obstetric

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study. https://app.cochat.ai/papers/10.1210/jc.2010-0853
The paper
Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K. F., Bunford, G., Lund, A., Bjerke, C., Almås, I., Berg, A. H., Danielson, A., Lahmami, G., & Carlsen, S. M. (2010). Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-0853

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.